Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 7Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Lymphoma, Follicular 6Lymphoma 6Multiple Myeloma 4Neoplasms, Plasma Cell 3Leukemia, Myeloid, Acute 3Waldenstrom Macroglobulinemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Kidney Neoplasms 2Immunoglobulin Light-chain Amyloidosis 2Carcinoma, Renal Cell 2Burkitt Lymphoma 2Breast Neoplasms 2Unspecified Childhood Solid Tumor, Protocol Specific 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1

Interventions

Peripheral Blood Stem Cell Transplantation 4Azacitidine 4fludarabine phosphate 2Lenalidomide 2Decitabine 2Cytarabine 2Cyclophosphamide 2treosulfan 1sargramostim 1eprenetapopt 1aldesleukin 1Whole-Body Irradiation 1Therapeutics 1Tacrolimus 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Levofloxacin 1Ketamine 1Idarubicin 1Histamine 1Flow Cytometry 1Filgrastim 1Etoposide 1Cefepime 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelomonocytic, Chronic × sargramostim × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡